As of 2026-03-31, 泰瑞沙's data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 2.04%, below the industry average by 0.2 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Positive mention rate (2.04%) is slightly higher than negative (0.00%), continue monitoring public sentiment. Among 6 competitors in the same category, 泰瑞沙's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
泰瑞沙's Mention Rate is 2.04%, lower than 0.6% of competitors
泰瑞沙's First Mention is 0.00%, lower than 0.9% of competitors
泰瑞沙's Preferred Rate is 0.00%, lower than 100.0% of competitors
泰瑞沙's Positive Rate is 2.04%, lower than 8.9% of competitors
泰瑞沙's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 立立普妥 | 6.12% | 0% | 0% | 4.08% | 0% | View Details |
| PPaxlovid | 4.08% | 0% | 0% | 4.08% | 0% | View Details |
| ZZepbound | 4.08% | 0% | 0% | 4.08% | 0% | View Details |
| 帕帕博利珠单抗 | 4.08% | 0% | 0% | 4.08% | 0% | View Details |
| 得得福组合 | 4.08% | 0% | 0% | 4.08% | 0% | View Details |
| 苯苯磺酸左氨氯地平片 | 4.08% | 0% | 0% | 4.08% | 0% | View Details |
| 泰泰瑞沙 (Current Brand) | 2.04% | 0% | 0% | 2.04% | 0% | View Details |
